Literature DB >> 27284329

Chinese herbal formula QHF inhibits liver cancer cell invasion and migration.

Tao Chen1, Quan Wang1, Yunxiao Li1, Hefei Huang1, Wei Hu1.   

Abstract

The aim of the present study was to observe the effects of the Chinese herbal formula QHF (Q, Qingrejiedu; H, Huoxuehuayu; and F, Fuzhengguben) on the migration and invasion of hepatocellular carcinoma (HCC) HepG2 cells and to elucidate the potential molecular mechanisms involved. HepG2 cells were treated with various concentrations of QHF, and scratch and Transwell® migration assays were used to qualitatively analyze differences in the migration and invasion activity of these cells. Extracellular signal-regulated kinase (ERK), p38 and c-Jun N-terminal kinase (JNK) inhibitors were subsequently introduced in order to study the association between QHF and the invasion of HepG2 cells. The protein expression levels of the mitogen-activated protein kinase (MAPK) signaling pathway in HepG2 cells in the presence and absence of QHF were additionally determined using western blot analysis. The results showed that QHF significantly inhibited the proliferation of the HepG2 cells in a concentration-dependent manner, in addition to inhibiting cell movement, which reduced the ability of the cells to invade and migrate. Western blot analysis indicated that the effects of QHF on HCC HepG2 cells after 24 h were to significantly decrease the expression of phosphorylated- (p-)ERK and to increase the expression of p-p38 and p-JNK; however, the total quantity of ERK, p38 and JNK protein remained unchanged. The administration of an inhibitor of ERK altered p38 and JNK expression and promoted the anti-invasion effects of QHF, whereas p38 and JNK inhibitors only partially reversed this effect. The results of the present study indicate, therefore, that QHF is able to inhibit the migratory and invasive activity of HepG2 cells. A possible underlying mechanism involves the activation of the p38 and JNK MAPK signaling pathway and the attenuation of the ERK signaling pathway.

Entities:  

Keywords:  Chinese herbal formula; QHF; hepatocellular carcinoma; invasion; migration; mitogen-activated protein kinase

Year:  2016        PMID: 27284329      PMCID: PMC4888004          DOI: 10.3892/etm.2016.3247

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  8 in total

1.  Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.

Authors:  Mi-Kyung Song; Youn-Jung Kim; Mee Song; Han-Seam Choi; Yong-Keun Park; Jae-Chun Ryu
Journal:  Cancer Sci       Date:  2011-07-08       Impact factor: 6.716

2.  JNK suppresses tumor formation via a gene-expression program mediated by ATF2.

Authors:  Malgorzata Gozdecka; Stephen Lyons; Saki Kondo; Janet Taylor; Yaoyong Li; Jacek Walczynski; Gerald Thiel; Wolfgang Breitwieser; Nic Jones
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

3.  c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice.

Authors:  Sanda Win; Tin Aung Than; Derick Han; Lydia M Petrovic; Neil Kaplowitz
Journal:  J Biol Chem       Date:  2011-08-15       Impact factor: 5.157

4.  Trientine, a copper-chelating agent, induced apoptosis in murine fibrosarcoma cells by activation of the p38 MAPK pathway.

Authors:  Shingo KADOWAKI; Daiji ENDOH; Toyo OKUI; Masanobu HAYASHI
Journal:  J Vet Med Sci       Date:  2009-11       Impact factor: 1.267

5.  Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.

Authors:  Shu-Ching Hsieh; Jen-Pi Tsai; Shun-Fa Yang; Meng-Ju Tang; Yi-Hsien Hsieh
Journal:  Amino Acids       Date:  2014-09-23       Impact factor: 3.520

6.  Screening of QHF formula for effective ingredients from Chinese herbs and its anti-hepatic cell cancer effect in combination with chemotherapy.

Authors:  Tao Chen; Dan Li; Ya-ling Fu; Wei Hu
Journal:  Chin Med J (Engl)       Date:  2008-02-20       Impact factor: 2.628

7.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase.

Authors:  N Johansson; R Ala-aho; V Uitto; R Grénman; N E Fusenig; C López-Otín; V M Kähäri
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

8.  In vivo and in vitro effects of QHF combined with chemotherapy on hepatocellular carcinoma.

Authors:  Chen Tao; Li Dan; Fuya Ling; Gongzi Peng
Journal:  J Biomed Res       Date:  2010-03
  8 in total
  4 in total

1.  Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.

Authors:  Hua Sui; Peiwen Duan; Piaoting Guo; Lishuang Hao; Xuan Liu; Jinhua Zhang; Huirong Zhu; Miaomiao Zhao; Hao Wang; Qi Li; Songpo Wang
Journal:  Oncol Rep       Date:  2017-08-23       Impact factor: 3.906

2.  Ping-Chong-Jiang-Ni Formula Induces Apoptosis and Inhibits Proliferation of Human Ectopic Endometrial Stromal Cells in Endometriosis via the Activation of JNK Signaling Pathway.

Authors:  Rui-Ning Liang; Pei-Shuang Li; Yang Zou; Yu-Ling Liu; Zhen Jiang; Zhen Liu; Pei Fan; Ling Xu; Jia-Hua Peng; Xue-Yan Sun
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-01       Impact factor: 2.629

3.  Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.

Authors:  Zhongjun Wu
Journal:  Anticancer Agents Med Chem       Date:  2017       Impact factor: 2.505

4.  Chinese Herbal Formulas Miao-Yi-Ai-Tang Inhibits the Proliferation and Migration of Lung Cancer Cells through Targeting β-Catenin/AXIN and Presents Synergistic Effect with Cisplatin Suppressing Lung Cancer.

Authors:  Bo Li; Wei Zhang; Tao Tan; Wei Liu; Xian Luo; Jun Zhang; Yi Yang; Ruogu Li; Zhengxing Ge
Journal:  Biomed Res Int       Date:  2020-01-16       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.